STOCK TITAN

Healthcare Services Group (HCSG) director granted 611 deferred stock units

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Simmons Kurt JR reported acquisition or exercise transactions in this Form 4 filing.

Healthcare Services Group Inc. director Kurt JR Simmons reported a compensation-related stock grant. He received 611 shares of common stock at $24.56 per share as a grant or award, bringing his direct holdings to 30,770 shares.

According to the disclosure, Simmons has elected to receive fully vested Deferred Stock Units instead of cash fees for his board and committee service under the 2020 Omnibus Incentive Plan. These DSUs will be settled in common shares on the earlier of January 1, 2031, his death, disability, separation from service, or a Change of Control, with the option to defer further under Code Section 409A.

Positive

  • None.

Negative

  • None.
Insider Simmons Kurt JR
Role null
Type Security Shares Price Value
Grant/Award Common Stock 611 $24.56 $15K
Holdings After Transaction: Common Stock — 30,770 shares (Direct, null)
Footnotes (1)
  1. The reporting person has elected to receive fully vested shares of Deferred Stock Units ("DSUs") under the Issuer's 2020 Omnibus Incentive Plan in lieu of cash fees payable for service on the Issuer's Board of Directors and any committees thereof. The reporting person made this election in 2025 which applies to Director's fees earned in 2026 in compliance with the Issuer's blackout period guidelines. The number of shares represents the quotient of the amount of such fees divided by the Issuer's closing stock price on the date such fees would otherwise be paid, rounded up to the nearest whole share. Such DSUs will be settled in shares of common stock on the first to occur of (i) January 1, 2031; (ii) the Participant's date of death, disability or separation from service; or (iii) the date of a Change of Control (the "Settlement Date"). The reporting person may elect a further deferral beyond the Settlement Date pursuant to the rules of Code Section 409A. Amount represents 1,969 unvested DSUs and 28,801 vested DSUs.
Stock grant size 611 shares Common stock granted as DSUs on 2026-06-30
Grant price $24.56 per share Implied value for DSU-based fee conversion
Total direct holdings 30,770 shares Shares held after the reported transaction
Unvested DSUs 1,969 units Unvested Deferred Stock Units noted in footnote
Vested DSUs 28,801 units Vested Deferred Stock Units noted in footnote
Earliest settlement date January 1, 2031 First possible DSU settlement date under plan
Deferred Stock Units financial
"The reporting person has elected to receive fully vested shares of Deferred Stock Units ("DSUs") under the Issuer's 2020 Omnibus Incentive Plan"
Deferred stock units are promises from a company to give an employee shares of stock at a future date, often after certain conditions are met or after leaving the company. They function like a form of delayed compensation, allowing employees to earn shares over time. For investors, they represent potential future ownership in the company, but do not provide immediate voting rights or dividends until the shares are actually received.
2020 Omnibus Incentive Plan financial
"Deferred Stock Units ("DSUs") under the Issuer's 2020 Omnibus Incentive Plan in lieu of cash fees payable"
blackout period guidelines regulatory
"The reporting person made this election in 2025 which applies to Director's fees earned in 2026 in compliance with the Issuer's blackout period guidelines"
Change of Control financial
"settled in shares of common stock on the first to occur of (i) January 1, 2031; (ii) the Participant's date of death, disability or separation from service; or (iii) the date of a Change of Control"
A change of control occurs when the ownership or management of a company shifts significantly, such as through a sale, merger, or acquisition, resulting in new leadership or ownership structure. This change can impact the company's direction and decision-making, which is important for investors because it may affect the company's stability, strategy, and future prospects.
Code Section 409A regulatory
"The reporting person may elect a further deferral beyond the Settlement Date pursuant to the rules of Code Section 409A"
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Simmons Kurt JR

(Last)(First)(Middle)
3220 TILLMAN DRIVE
SUITE 300

(Street)
BENSALEM PENNSYLVANIA 19020

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
HEALTHCARE SERVICES GROUP INC [ HCSG ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
06/30/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock06/30/2026A611A$24.56(1)30,770(2)D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. The reporting person has elected to receive fully vested shares of Deferred Stock Units ("DSUs") under the Issuer's 2020 Omnibus Incentive Plan in lieu of cash fees payable for service on the Issuer's Board of Directors and any committees thereof. The reporting person made this election in 2025 which applies to Director's fees earned in 2026 in compliance with the Issuer's blackout period guidelines. The number of shares represents the quotient of the amount of such fees divided by the Issuer's closing stock price on the date such fees would otherwise be paid, rounded up to the nearest whole share. Such DSUs will be settled in shares of common stock on the first to occur of (i) January 1, 2031; (ii) the Participant's date of death, disability or separation from service; or (iii) the date of a Change of Control (the "Settlement Date"). The reporting person may elect a further deferral beyond the Settlement Date pursuant to the rules of Code Section 409A.
2. Amount represents 1,969 unvested DSUs and 28,801 vested DSUs.
Remarks:
Michael Harrity, by Power of Attorney07/02/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did HCSG director Kurt JR Simmons report?

HCSG director Kurt JR Simmons reported receiving 611 shares of common stock as a grant or award at $24.56 per share. This is compensation for board service rather than an open-market purchase, increasing his direct holdings to 30,770 shares.

How did Kurt JR Simmons structure his HCSG board compensation?

Kurt JR Simmons elected to receive fully vested Deferred Stock Units instead of cash fees for serving on the board and its committees. The number of DSUs equals his fees divided by HCSG’s closing stock price on the payment date, rounded up to the nearest whole share.

When will HCSG Deferred Stock Units held by Kurt JR Simmons be settled?

The Deferred Stock Units will be settled in HCSG common stock on the earliest of January 1, 2031, Simmons’s death, disability, separation from service, or a Change of Control. He may also elect a further deferral under Internal Revenue Code Section 409A.

How many HCSG Deferred Stock Units does Kurt JR Simmons currently hold?

Simmons’s position includes 1,969 unvested Deferred Stock Units and 28,801 vested Deferred Stock Units. Together, these DSUs represent 30,770 shares of HCSG common stock that will be delivered upon settlement events described in the company’s incentive plan.

Is the HCSG Form 4 transaction an open-market buy or a compensation grant?

The Form 4 shows a compensation grant, not an open-market buy. The transaction is coded as a grant, award, or other acquisition, reflecting Simmons’s election to receive Deferred Stock Units in lieu of cash board fees under HCSG’s 2020 Omnibus Incentive Plan.